In a fascinating conversation featured on ynet, Gil Horsky shared his vision for the future of global nutrition. Horsky, who previously founded the corporate venture capital arm of the snacking giant Mondelēz, identifies the emergence of an entirely new category within the industry—one that bridges the gap between the food and pharmaceutical worlds.
“I believe that in the near future, we will see an industry that can be called ‘Food as Medicine’,” Horsky stated during the interview. He describes this as functional food backed by specific clinical trials, providing consumers with proven, data-driven health benefits. Horsky points to Nestle Health Science as a prime example of a division already moving in this direction by developing advanced nutritional solutions.
Horsky explains that the connection between these industries is expected to become symbiotic—no longer two separate systems, but one unified approach focused on prevention and treatment through the plate. “My vision is the creation of a category where food itself serves as both a preventative and therapeutic tool,” he concludes. The ynet feature highlights that this intersection is where the true new value is being created for both consumers and investors alike.